Eiji Suzuki

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

Javier Cortés, David W. Cescon, Hope S. Rugo et al. · The Lancet · 2020 · 1.7K citations · Full text

Chemotherapy Versus Placebo, Breast Oncology, Oncology +7

Gemcitabine Selectively Eliminates Splenic Gr-1+/CD11b+ Myeloid Suppressor Cells in Tumor-Bearing Animals and Enhances Antitumor Immune Activity

Eiji Suzuki, Veena Kapoor, Arminder S. Jassar et al. · Clinical Cancer Research · 2005 · 1K citations

Alkyl-Functionalized Organic Dyes for Efficient Molecular Photovoltaics

Nagatoshi Koumura, Zhong‐Sheng Wang, Shogo Mori et al. · Journal of the American Chemical Society · 2006 · 872 citations

Materials Science, Mk-2 Dye, Chemical Engineering +15

Neutrophils Kill Antibody-Opsonized Cancer Cells by Trogoptosis

Hanke L. Matlung, Liane Babes, Xi Zhao et al. · Cell Reports · 2018 · 372 citations · Full text

Arabidopsis IRE1 catalyses unconventional splicing of bZIP60 mRNA to produce the active transcription factor

Yukihiro Nagashima, Kei‐ichiro Mishiba, Eiji Suzuki et al. · Scientific Reports · 2011 · 330 citations · Full text

Genetics, Rna Splicing, Molecular Biology +19